Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Universal screening of newborns for biliary atresia: Cost-effectiveness of alternative strategies.

Masucci L, Schreiber RA, Kaczorowski J, Collet JP, Bryan S.

J Med Screen. 2019 Sep;26(3):113-119. doi: 10.1177/0969141319832039. Epub 2019 Mar 14. No abstract available.

PMID:
30871409
2.

Province-wide Biliary Atresia Home Screening Program in British Columbia: Evaluation of First 2 Years.

Woolfson JP, Schreiber RA, Butler AE, MacFarlane J, Kaczorowski J, Masucci L, Bryan S, Collet JP.

J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):845-849. doi: 10.1097/MPG.0000000000001950.

PMID:
29570556
3.

Clinical Characteristics and Complications of Pediatric Liver Biopsy: A Single Centre Experience.

Almeida P, Schreiber RA, Liang J, Mujawar Q, Guttman OR.

Ann Hepatol. 2017 Sep-Oct;16(5):797-801. doi: 10.5604/01.3001.0010.2809.

4.

Antenatal Treatment with Intravenous Immunoglobulin to Prevent Gestational Alloimmune Liver Disease: Comparative Effectiveness of 14-Week versus 18-Week Initiation.

Whitington PF, Kelly S, Taylor SA, Nóbrega S, Schreiber RA, Sokal EM, Hibbard JU.

Fetal Diagn Ther. 2018;43(3):218-225. doi: 10.1159/000477616. Epub 2017 Aug 5.

PMID:
28787718
5.

Screening for biliary atresia: it's in the cards.

Schreiber RA, Butler A.

Can Fam Physician. 2017 Jun;63(6):424-425. No abstract available.

6.

Management of Pediatric Nonalcoholic Fatty Liver Disease by Academic Hepatologists in Canada: A Nationwide Survey.

Mouzaki M, Ling SC, Schreiber RA, Kamath BM.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):380-383. doi: 10.1097/MPG.0000000000001581.

PMID:
28333768
7.

Response to: Comment on "Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography".

Chen B, Schreiber RA, Human DG, Potts JE, Guttman OR.

Can J Gastroenterol Hepatol. 2017;2017:4217878. doi: 10.1155/2017/4217878. Epub 2017 Feb 8. No abstract available.

8.

A national retrospective study of paediatric end-stage liver disease as a predictor of change to second-line therapy in children with autoimmune hepatitis.

Zizzo AN, Jimenez-Rivera C, Kim J, Schreiber RA, Ling SC, Yap J, Critch J, Ahmed N, Alvarez F, Kamath BM; Canadian Paediatric Hepatology Research Group (CPHRG).

Liver Int. 2017 Oct;37(10):1562-1570. doi: 10.1111/liv.13387. Epub 2017 Mar 15.

PMID:
28199778
9.

Variability of diagnostic approach, surgical technique, and medical management for children with biliary atresia in Canada - Is it time for standardization?

Stagg H, Cameron BH, Ahmed N, Butler A, Jimenez-Rivera C, Yanchar NL, Martin SR, Emil S, Anthopoulos G, Schreiber RA, Laberge JM; Canadian Biliary Atresia Registry.

J Pediatr Surg. 2017 May;52(5):802-806. doi: 10.1016/j.jpedsurg.2017.01.041. Epub 2017 Jan 30.

PMID:
28189446
10.

JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome.

Del Bel KL, Ragotte RJ, Saferali A, Lee S, Vercauteren SM, Mostafavi SA, Schreiber RA, Prendiville JS, Phang MS, Halparin J, Au N, Dean JM, Priatel JJ, Jewels E, Junker AK, Rogers PC, Seear M, McKinnon ML, Turvey SE.

J Allergy Clin Immunol. 2017 Jun;139(6):2016-2020.e5. doi: 10.1016/j.jaci.2016.12.957. Epub 2017 Jan 19. No abstract available.

PMID:
28111307
11.

Clinical Characteristics and Complications of Pediatric Liver Biopsy: A Single Centre Experience.

Almeida P, Schreiber RA, Liang J, Mujawar Q, Guttman OR.

Ann Hepatol. 2017 Sep - Oct;16(5):797-801. doi: 10.5604/01.3001.0010.2809.

12.

Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography.

Chen B, Schreiber RA, Human DG, Potts JE, Guttman OR.

Can J Gastroenterol Hepatol. 2016;2016:7125193. Epub 2016 Aug 30.

13.

The Canadian Biliary Atresia Registry: Improving the care of Canadian infants with biliary atresia.

Butler AE, Schreiber RA, Yanchar N, Emil S, Laberge JM; Canadian Biliary Atresia Registry.

Paediatr Child Health. 2016 Apr;21(3):131-4.

14.

Biliary atresia and other cholestatic childhood diseases: Advances and future challenges.

Verkade HJ, Bezerra JA, Davenport M, Schreiber RA, Mieli-Vergani G, Hulscher JB, Sokol RJ, Kelly DA, Ure B, Whitington PF, Samyn M, Petersen C.

J Hepatol. 2016 Sep;65(3):631-42. doi: 10.1016/j.jhep.2016.04.032. Epub 2016 May 6. Review.

PMID:
27164551
15.

Incidence and Characteristics of Autoimmune Hepatitis.

Jiménez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez F.

Pediatrics. 2015 Nov;136(5):e1237-48. doi: 10.1542/peds.2015-0578. Epub 2015 Oct 19.

16.

Re: The new Canadian Association for the Study of the Liver HCV guidelines.

Renner EL, Schreiber RA.

Can J Gastroenterol Hepatol. 2015 Apr;29(3):164. Epub 2015 Feb 25. No abstract available.

17.

Home-based screening for biliary atresia using infant stool colour cards: a large-scale prospective cohort study and cost-effectiveness analysis.

Schreiber RA, Masucci L, Kaczorowski J, Collet JP, Lutley P, Espinosa V, Bryan S.

J Med Screen. 2014 Sep;21(3):126-32. doi: 10.1177/0969141314542115. Epub 2014 Jul 9.

PMID:
25009198
18.

CLMP is required for intestinal development, and loss-of-function mutations cause congenital short-bowel syndrome.

Van Der Werf CS, Wabbersen TD, Hsiao NH, Paredes J, Etchevers HC, Kroisel PM, Tibboel D, Babarit C, Schreiber RA, Hoffenberg EJ, Vekemans M, Zeder SL, Ceccherini I, Lyonnet S, Ribeiro AS, Seruca R, Te Meerman GJ, van Ijzendoorn SC, Shepherd IT, Verheij JB, Hofstra RM.

Gastroenterology. 2012 Mar;142(3):453-462.e3. doi: 10.1053/j.gastro.2011.11.038. Epub 2011 Dec 7.

PMID:
22155368
19.

Does adjuvant steroid therapy post-Kasai portoenterostomy improve outcome of biliary atresia? Systematic review and meta-analysis.

Sarkhy A, Schreiber RA, Milner RA, Barker CC.

Can J Gastroenterol. 2011 Aug;25(8):440-4. Review.

20.

Biliary atresia with associated structural malformations in Canadian infants.

Guttman OR, Roberts EA, Schreiber RA, Barker CC, Ng VL; Canadian Pediatric Hepatology Research Group.

Liver Int. 2011 Nov;31(10):1485-93. doi: 10.1111/j.1478-3231.2011.02578.x. Epub 2011 Aug 8.

PMID:
21819536
21.

Abnormal liver transaminases and conjugated hyperbilirubinemia at presentation of acute lymphoblastic leukemia.

Segal I, Rassekh SR, Bond MC, Senger C, Schreiber RA.

Pediatr Blood Cancer. 2010 Sep;55(3):434-9. doi: 10.1002/pbc.22549.

PMID:
20658613
22.

Biliary atresia in Canada: the effect of centre caseload experience on outcome.

Schreiber RA, Barker CC, Roberts EA, Martin SR; Canadian Pediatric Hepatology Research Group.

J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):61-5. doi: 10.1097/MPG.0b013e3181d67e5e.

PMID:
20543720
23.

Biliary atresia: the timing needs a changin'.

Chitsaz E, Schreiber RA, Collet JP, Kaczorowski J.

Can J Public Health. 2009 Nov-Dec;100(6):475-7.

PMID:
20209745
24.

Biliary atresia: the Canadian experience.

Schreiber RA, Barker CC, Roberts EA, Martin SR, Alvarez F, Smith L, Butzner JD, Wrobel I, Mack D, Moroz S, Rashid M, Persad R, Levesque D, Brill H, Bruce G, Critch J; Canadian Pediatric Hepatology Research Group.

J Pediatr. 2007 Dec;151(6):659-65, 665.e1. Epub 2007 Oct 22.

PMID:
18035148
25.

Inflammatory bowel disease in the South Asian pediatric population of British Columbia.

Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K.

Am J Gastroenterol. 2007 May;102(5):1077-83. Epub 2007 Mar 22.

PMID:
17378907
26.

Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful?

Ebbeson RL, Schreiber RA.

Clin Gastroenterol Hepatol. 2004 Oct;2(10):935-40.

PMID:
15476158
27.

Biliary atresia.

Schreiber RA, Kleinman RE.

J Pediatr Gastroenterol Nutr. 2002;35 Suppl 1:S11-6. Review. No abstract available.

PMID:
12151815
28.

Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly.

Gillett PM, Schreiber RA, Jevon GP, Israel DM, Warshawski T, Vallance H, Clarke LA.

J Pediatr Gastroenterol Nutr. 2001 Aug;33(2):216-20. Review. No abstract available.

PMID:
11568529
29.

Jaundice in older children and adolescents.

Pashankar D, Schreiber RA.

Pediatr Rev. 2001 Jul;22(7):219-26. Review. No abstract available.

PMID:
11435623
30.

Neonatal cholestasis: a red alert for the jaundiced newborn.

Pashankar D, Schreiber RA.

Can J Gastroenterol. 2000 Nov;14 Suppl D:67D-72D. Review.

PMID:
11110615
31.

Perianal Crohn's disease in infancy.

Pashankar D, Schreiber RA, Israel DM.

J Pediatr Gastroenterol Nutr. 2000 Jul;31(1):80-2. No abstract available.

PMID:
10896077
32.

Life-threatening gastrointestinal hemorrhage due to juvenile polyposis.

Pashankar D, Murphy JJ, Ostry A, Schreiber RA.

Am J Gastroenterol. 2000 Feb;95(2):543-5.

PMID:
10685766
33.

Propranolol and portal hypertension: should kids be on the block?

Schreiber RA.

J Pediatr Gastroenterol Nutr. 1999 Jul;29(1):10-1. No abstract available.

PMID:
10400096
34.

Vascular abnormalities in Adams-Oliver syndrome: cause or effect?

Swartz EN, Sanatani S, Sandor GG, Schreiber RA.

Am J Med Genet. 1999 Jan 1;82(1):49-52.

PMID:
9916843
35.

Arterioportal fistula in a child with biliary atresia.

Pashankar D, Schreiber RA, Culham G.

Gastroenterology. 1998 Apr;114(4):862-3. No abstract available.

PMID:
9547112
36.

Decompression of portal hypertension in a child with cystic fibrosis after transjugular intrahepatic portosystemic shunt placement.

Berger KJ, Schreiber RA, Tchervenkov J, Kopelman H, Brassard R, Stein L.

J Pediatr Gastroenterol Nutr. 1994 Oct;19(3):322-5. No abstract available.

PMID:
7815265
37.

Genetics, immunology, and biliary atresia: an opening or a diversion?

Schreiber RA, Kleinman RE.

J Pediatr Gastroenterol Nutr. 1993 Feb;16(2):111-3. No abstract available.

PMID:
8450373
38.

Rejection of murine congenic bile ducts: a model for immune-mediated bile duct disease.

Schreiber RA, Kleinman RE, Barksdale EM Jr, Maganaro TF, Donahoe PK.

Gastroenterology. 1992 Mar;102(3):924-30.

PMID:
1537528
39.

Food allergy: facts and fiction.

Schreiber RA, Walker WA.

Mayo Clin Proc. 1989 Nov;64(11):1381-91. Review.

PMID:
2687597
40.

The gastrointestinal barrier: antigen uptake and perinatal immunity.

Schreiber RA, Walker WA.

Ann Allergy. 1988 Dec;61(6 Pt 2):3-12. Review. No abstract available.

PMID:
3061319
41.

Behavior genetics of audiogenic seizures in DBA/2J and Rb-1 mice.

Schreiber RA.

Behav Genet. 1986 May;16(3):365-8. No abstract available.

PMID:
3753371
42.
43.
44.

Glucose protects DBA/2J mice from audiogenic seizures: correlation with brain glycogen levels.

Schreiber RA, Ungar AL.

Psychopharmacology (Berl). 1984;84(1):128-31.

PMID:
6436881
45.

Effect of ethanol on audiogenic seizures in C57BL/6J and DBA/2J mice.

Schreiber RA.

Subst Alcohol Actions Misuse. 1982;3(6):325-30.

PMID:
7185202
46.

Ethanol induces a transient susceptibility to audiogenic seizures in weanling C57BL/6J mice.

Schreiber RA.

Subst Alcohol Actions Misuse. 1982;3(3):145-52.

PMID:
7170674
47.

A proposed mechanism for the anticonvulsant action of valproate.

Schreiber RA.

Med Hypotheses. 1981 Nov;7(11):1377-87.

PMID:
6798375
48.
49.

Ethanol during weaning induces a transient susceptibility to audiogenic seizures in Rb mice.

Schreiber RA, Lehmann A.

Dev Psychobiol. 1981 May;14(3):181-6. No abstract available.

PMID:
7196353
50.

Supplemental Content

Loading ...
Support Center